Thermo Fisher Scientific Completes Acquisition of Patheon

WALTHAM, Mass., Aug. 29, 2017 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it has completed its acquisition of Patheon N.V. (NYSE: PTHN), a leading contract development and manufacturing organization (CDMO) serving the pharmaceutical and biotechnology sectors, for approximately $7.2 billion. Today’s close follows the expiration of... Read more

Luminex Corporation and Sutter Health Collaborate to Improve Patient Care

AUSTIN, Texas, Aug. 29, 2017 /PRNewswire/ — Luminex Corporation (NASDAQ: LMNX), and Sutter Health, a not-for-profit health system in Northern California, today announced a collaboration to help advance patient care by improving the health network’s ability to quickly and accurately diagnose a range of conditions, including Cystic Fibrosis, gastrointestinal illness, and respiratory tract infections. Using a... Read more

MilliporeSigma to Acquire Natrix Separations to Advance Next-Generation Processing Capabilities

Boosts MilliporeSigma’s single-use chromatography portfolio Accelerates MilliporeSigma’s mAb and vaccine manufacturing offering Billerica, Massachusetts, August 28, 2017 — MilliporeSigma today announced that it has entered into an agreement to acquire Natrix Separations, an Ontario, Canada-based provider of hydrogel membrane products for single-use chromatography. The transaction is expected to close in Q3 of 2017. Financial details were not disclosed.... Read more

Illumina and Telegraph Hill Partners Launch Verogen, Inc. to Drive Adoption of Next-Generation Sequencing in the Global Forensic Genomics Market

SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) today announced plans with Telegraph Hill Partners (THP), a San Francisco-based venture capital and growth equity firm, to establish Verogen, Inc. The independent new company has certain exclusive rights to provide Illumina’s forensic sequencing technology to forensic customers, including for criminal casework and other human and nonhuman forensic applications.... Read more

Thermo Fisher Scientific Announces Receipt of All Required Regulatory Approvals for Proposed Acquisition of Patheon

Thermo Fisher Scientific Announces Receipt of All Required Regulatory Approvals for Proposed Acquisition of Patheon Tender Offer Scheduled to Expire at 5:00 p.m., New York City Time, on August 28, 2017 WALTHAM, Mass., Aug. 23, 2017 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that all required antitrust clearances have... Read more

Brooks Automation Announces the Acquisition of Software Assets

CHELMSFORD, Mass., Aug. 22, 2017 (GLOBE NEWSWIRE) — Brooks Automation, Inc. (Nasdaq:BRKS), announced today that it has acquired certain assets from RURO, Inc., based in Frederick, MD. These assets include the FreezerPro® web-based software which enables access to information on stored samples from any location on any device. As part of the acquisition, Brooks also... Read more

Helix Teams Up with Illumina Accelerator to Drive Innovation and DNA-Powered Products for Consumers

Calling innovative startups building consumer applications to deliver DNA insights powered by Helix’s Exome+ and next generation sequencing August 17, 2017 05:00 AM Pacific Daylight Time SAN CARLOS, Calif.–(BUSINESS WIRE)–Helix, a personal genomics company, today announced a collaboration with Illumina Accelerator, the world’s first business accelerator focused solely on creating an innovation ecosystem for the... Read more

Roka Bioscience, Inc. Agrees to Sell its Assets to Subsidiary of Institute for Environmental Health, Inc.

Roka Bioscience, Inc. Agrees to Sell its Assets to Subsidiary of Institute for Environmental Health, Inc. WARREN, N.J., Aug. 17, 2017 /PRNewswire/ — Roka Bioscience, Inc. (NASDAQ: ROKA), a molecular diagnostics company focused on providing advanced testing solutions for the detection of foodborne pathogens, today announced that it has entered into an asset purchase agreement with... Read more

Fluidigm Licenses CFTR Next-Generation Sequencing Assay From Baylor Genetics for Use With the Juno System

SOUTH SAN FRANCISCO, Calif., Aug. 17, 2017 (GLOBE NEWSWIRE) — Fluidigm Corporation (NASDAQ:FLDM) and Baylor Genetics today announced that they have entered into a licensing agreement to offer a next-generation sequencing (NGS) library prep assay that enables efficient sequencing of the CFTR (cystic fibrosis transmembrane conductance regulator) gene. Under the agreement, Fluidigm obtains the rights to commercialize the CFTR library prep... Read more